MADISON LOWRY

Allopathic & Osteopathic Physicians|Family Medicine NEW BRAUNFELS, TX NPI 1639129265

General Payments — all program years on this page

$4,149.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 90
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $795.39 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $795.3916

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $689.7116
2019 $413.367
2020 $78.675
2021 $326.0814
2022 $609.3412
2023 $1,236.7120
2024 $795.3916

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086188718 Bayer Healthcare Pharmaceuticals Inc. $30.18 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089512990 Currax Pharmaceuticals LLC $17.27 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104677963 AstraZeneca Pharmaceuticals LP $70.51 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105745376 AstraZeneca Pharmaceuticals LP $75.80 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105855394 AstraZeneca Pharmaceuticals LP $16.47 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117314484 Amgen Inc. $150.00 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118088590 Boehringer Ingelheim Pharmaceuticals, Inc. $111.42 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131877550 PFIZER INC. $13.15 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135145487 Lilly USA, LLC $24.09 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135160334 Lilly USA, LLC $2.41 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135162003 Lilly USA, LLC $17.06 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135162111 Lilly USA, LLC $97.32 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135162113 Lilly USA, LLC $23.95 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135162115 Lilly USA, LLC $15.39 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141755918 Merck Sharp & Dohme LLC $68.66 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148075520 Inspire Medical Systems, Inc. $61.71 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.